MACC1 mRNA Levels Predict Cancer Recurrence After Resection of Colorectal Cancer Liver Metastases

Predictive Factors for the Benefit of Perioperative FOLFOX for Resectable Liver Metastasis in Colorectal Cancer Patients (EORTC Intergroup Trial 40983)

(2012) Halfdan Sorbye et al.   ANNALS OF SURGERY

In vivo imaging of colorectal cancer growth and metastasis by targeting MACC1 with shRNA in xenografted mice

(2012) Andreas Pichorner et al.   CLINICAL & EXPERIMENTAL METASTASIS

Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review

(2012) X. Liao et al.   CLINICAL CANCER RESEARCH

MicroRNA-143 Targets MACC1 to Inhibit Cell Invasion and Migration in Colorectal cancer

(2012) Yu Zhang et al.   Molecular Cancer

Overexpression of metastasis-associated in colon cancer 1 predicts a poor outcome of hepatitis B virus-related hepatocellular carcinoma

(2012) Jian-Hui Qu   WORLD JOURNAL OF GASTROENTEROLOGY

Mulcom: a multiple comparison statistical test for microarray data in Bioconductor

(2011) Claudio Isella et al.   BMC BIOINFORMATICS

MACC1 controls Met: What a difference an Sp1 site makes

(2011) Ulrike Stein et al.   CELL CYCLE

MiR-1 Downregulation Cooperates with MACC1 in Promoting MET Overexpression in Human Colon Cancer

(2011) C. Migliore et al.   CLINICAL CANCER RESEARCH

Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations

(2011) F. Galimi et al.   CLINICAL CANCER RESEARCH

KRAS Mutation Is Associated with Lung Metastasis in Patients with Curatively Resected Colorectal Cancer

(2011) J. Tie et al.   CLINICAL CANCER RESEARCH

Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases

(2011) Giorgio Ercolani et al.   EUROPEAN JOURNAL OF CANCER

Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer

(2011) Gordon Hutchins et al.   JOURNAL OF CLINICAL ONCOLOGY

Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells

(2011) Ruitao Zhang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma

(2011) Jiliang Qiu et al.   Journal of Translational Medicine

Improving the clinical risk score: An analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases

(2011) Shishir K. Maithel et al.   SURGERY

A Molecularly Annotated Platform of Patient-Derived Xenografts ("Xenopatients") Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer

(2011) A. Bertotti et al.   Cancer Discovery

PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer patients with poor prognosis

(2011) Arantza Fariña Sarasqueta et al.   CELLULAR ONCOLOGY

KRAS mutation detection and prognostic potential in sporadic colorectal cancer using high-resolution melting analysis

(2010) V Deschoolmeester et al.   BRITISH JOURNAL OF CANCER

A Genome-Wide Screen for Microdeletions Reveals Disruption of Polarity Complex Genes in Diverse Human Cancers

(2010) S. M. Rothenberg et al.   CANCER RESEARCH

Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus Leucovorin

(2010) Michael J. O'Connell et al.   JOURNAL OF CLINICAL ONCOLOGY

Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence

(2010) Hidehiko Shimokawa et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel

(2009) B. Nordlinger et al.   ANNALS OF ONCOLOGY

KRAS Mutation Correlates With Accelerated Metastatic Progression in Patients With Colorectal Liver Metastases

(2009) Garrett M. Nash et al.   ANNALS OF SURGICAL ONCOLOGY

Validation of Prognostic Scoring Systems for Patients Undergoing Resection of Colorectal Cancer Liver Metastases

(2009) Christoph Reissfelder et al.   ANNALS OF SURGICAL ONCOLOGY

Resection Margin and Recurrence-Free Survival After Liver Resection of Colorectal Metastases

(2009) Andrea Muratore et al.   ANNALS OF SURGICAL ONCOLOGY

KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803

(2009) S. Ogino et al.   CLINICAL CANCER RESEARCH

Colon cancer metastasis: MACC1 and Met as metastatic pacemakers

(2009) Franziska Arlt et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

MACC1 — more than metastasis? Facts and predictions about a novel gene

(2009) Ulrike Stein et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Overexpression of MACC1 leads to downstream activation of HGF/MET and potentiates metastasis and recurrence of colorectal cancer

(2009) Lisa A Boardman   Genome Medicine

Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials

(2008) Emmanuel Mitry et al.   JOURNAL OF CLINICAL ONCOLOGY

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

(2008) Bernard Nordlinger et al.   LANCET

MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis

(2008) Ulrike Stein et al.   NATURE MEDICINE